Cite
MLA Citation
Markus P Schlaich et al.. “Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.” Lancet, vol. 400, no. 10367, 2022, pp. 1927–1937. http://access.bl.uk/ark:/81055/vdc_100170509059.0x000051